Review



human mgmt open reading frame orf plasmid  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    OriGene human mgmt open reading frame orf plasmid
    Differential expression of BC200 RNA in GB cell lines. ( A ) The differential expression of BC200 RNA in GB cell lines and normal human astrocytes are shown. ( B ) The viability of GB cells was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( C ) Flow cytometry analysis of the ALDH1 + /CD133 + portion in GB cell lines and normal human astrocytes. ( D ) The level of BC200, BCRP1, MDR1, MRP1 and <t>MGMT</t> in GB cell lines was analyzed using RT-qPCR. * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Human Mgmt Open Reading Frame Orf Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/MGMT+(NM_002412)+Human+Tagged+ORF+Clone/pmc07463574-57-1-11
    Average 93 stars, based on 6 article reviews
    human mgmt open reading frame orf plasmid - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness"

    Article Title: Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness

    Journal: Cells

    doi: 10.3390/cells9081859

    Differential expression of BC200 RNA in GB cell lines. ( A ) The differential expression of BC200 RNA in GB cell lines and normal human astrocytes are shown. ( B ) The viability of GB cells was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( C ) Flow cytometry analysis of the ALDH1 + /CD133 + portion in GB cell lines and normal human astrocytes. ( D ) The level of BC200, BCRP1, MDR1, MRP1 and MGMT in GB cell lines was analyzed using RT-qPCR. * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Figure Legend Snippet: Differential expression of BC200 RNA in GB cell lines. ( A ) The differential expression of BC200 RNA in GB cell lines and normal human astrocytes are shown. ( B ) The viability of GB cells was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( C ) Flow cytometry analysis of the ALDH1 + /CD133 + portion in GB cell lines and normal human astrocytes. ( D ) The level of BC200, BCRP1, MDR1, MRP1 and MGMT in GB cell lines was analyzed using RT-qPCR. * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Techniques Used: Quantitative Proteomics, Sulforhodamine B Assay, Flow Cytometry, Quantitative RT-PCR

    BC200 RNA promotes TMZ resistance in GB through sponge miR-218-5p. ( A ) The viability of shBC200 and OEBC200 GB cell lines was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( B ) The levels of MGMT, BCRP1, MDR1, and MRP1 following shBC200 and OEBC200 in GB cells were determined through western blot. ( C ) MicroRNA profiling analyses showed that shBC200 and OEBC200 contained high and low levels of miR-218-5p, respectively. ( D ) LncBase Predicted v.2 predicted that a high binding score of miR-218-5p with BC200. ( E ) BC200 directly interacts with multiple binding sites to hsa-miR-218-5p. *** p < 0.001.
    Figure Legend Snippet: BC200 RNA promotes TMZ resistance in GB through sponge miR-218-5p. ( A ) The viability of shBC200 and OEBC200 GB cell lines was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( B ) The levels of MGMT, BCRP1, MDR1, and MRP1 following shBC200 and OEBC200 in GB cells were determined through western blot. ( C ) MicroRNA profiling analyses showed that shBC200 and OEBC200 contained high and low levels of miR-218-5p, respectively. ( D ) LncBase Predicted v.2 predicted that a high binding score of miR-218-5p with BC200. ( E ) BC200 directly interacts with multiple binding sites to hsa-miR-218-5p. *** p < 0.001.

    Techniques Used: Sulforhodamine B Assay, Western Blot, Binding Assay

    miR-218-5p regulated cell sphere formation, colony formation, and TMZ resistance in GB cells in vitro. ( A ) The differential expression of miR-218-5p in GB cell lines and normal human astrocytes. ( B ) Pearson’s correlation curve identified a negative correlation between BC200 and miR-218-5p in GB tissues. ( C ) Sphere formation assays showed that inhibition or mock transfection of miR-218-5p regulated GB cell stemness. ( D ) Colony formation assays showed that inhibition or mock transfection of miR-218-5p regulated GB cell survival. ( E ) The viability of GB cells with inhibition or mock transfection of miR-218-5p was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( F ) CCK-8 assay showed that inhibition or mock transfection of miR-218-5p had no effect on GB cell proliferation. ( G ) The protein levels of SOX2, Oct4, BRPC1, MRP1 and MDR1 with inhibition or mock transfection of miR-218-5p. ( H ) The protein levels of MGMT, MLH1, MSH2, MSH6 and PMS2 following inhibition or mock transfection of miR-218-5p in GB cells were determined through western blot. * p < 0.05, ** p < 0.01 and *** p < 0.001.
    Figure Legend Snippet: miR-218-5p regulated cell sphere formation, colony formation, and TMZ resistance in GB cells in vitro. ( A ) The differential expression of miR-218-5p in GB cell lines and normal human astrocytes. ( B ) Pearson’s correlation curve identified a negative correlation between BC200 and miR-218-5p in GB tissues. ( C ) Sphere formation assays showed that inhibition or mock transfection of miR-218-5p regulated GB cell stemness. ( D ) Colony formation assays showed that inhibition or mock transfection of miR-218-5p regulated GB cell survival. ( E ) The viability of GB cells with inhibition or mock transfection of miR-218-5p was analyzed through SRB assay 48 h after TMZ (0–1000 μM) treatment. ( F ) CCK-8 assay showed that inhibition or mock transfection of miR-218-5p had no effect on GB cell proliferation. ( G ) The protein levels of SOX2, Oct4, BRPC1, MRP1 and MDR1 with inhibition or mock transfection of miR-218-5p. ( H ) The protein levels of MGMT, MLH1, MSH2, MSH6 and PMS2 following inhibition or mock transfection of miR-218-5p in GB cells were determined through western blot. * p < 0.05, ** p < 0.01 and *** p < 0.001.

    Techniques Used: In Vitro, Quantitative Proteomics, Inhibition, Transfection, Sulforhodamine B Assay, CCK-8 Assay, Western Blot

    The lncRNA BC200 RNA sponges miR-218-5p regulated MGMT and MMR system enhancing self-renewal and TMZ resistance of GBM cells.
    Figure Legend Snippet: The lncRNA BC200 RNA sponges miR-218-5p regulated MGMT and MMR system enhancing self-renewal and TMZ resistance of GBM cells.

    Techniques Used:

    Related Articles

    Sequencing:

    Article Title: ATR inhibition reverses the resistance of homologous recombination deficient MGMT low /MMR proficient cancer cells to temozolomide
    Article Snippet: .. The human MGMT cDNA sequence was amplified using Phusion ® High-Fidelity DNA Polymerase (NEB) from the Myc-DDK-tagged MGMT cDNA template (Origene, NM_002412) and cloned into the lentiviral vector pCDH-pGK-puro using BamHI/EcoRI sites. ..

    Amplification:

    Article Title: ATR inhibition reverses the resistance of homologous recombination deficient MGMT low /MMR proficient cancer cells to temozolomide
    Article Snippet: .. The human MGMT cDNA sequence was amplified using Phusion ® High-Fidelity DNA Polymerase (NEB) from the Myc-DDK-tagged MGMT cDNA template (Origene, NM_002412) and cloned into the lentiviral vector pCDH-pGK-puro using BamHI/EcoRI sites. ..

    Clone Assay:

    Article Title: ATR inhibition reverses the resistance of homologous recombination deficient MGMT low /MMR proficient cancer cells to temozolomide
    Article Snippet: .. The human MGMT cDNA sequence was amplified using Phusion ® High-Fidelity DNA Polymerase (NEB) from the Myc-DDK-tagged MGMT cDNA template (Origene, NM_002412) and cloned into the lentiviral vector pCDH-pGK-puro using BamHI/EcoRI sites. ..

    Plasmid Preparation:

    Article Title: ATR inhibition reverses the resistance of homologous recombination deficient MGMT low /MMR proficient cancer cells to temozolomide
    Article Snippet: .. The human MGMT cDNA sequence was amplified using Phusion ® High-Fidelity DNA Polymerase (NEB) from the Myc-DDK-tagged MGMT cDNA template (Origene, NM_002412) and cloned into the lentiviral vector pCDH-pGK-puro using BamHI/EcoRI sites. ..

    Article Title: Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.
    Article Snippet: .. Low MGMT expressing cells U251, U87 and GB30 were transfected with human MGMT (NM_002412) MycDDK-tagged ORF clone plasmid (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA). .. Cells were seeded in 6-well plates at 1 × 106 cells/well and transfected with 2.5 µg human MGMT- pCMV6 or empty vector.

    Article Title: Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness
    Article Snippet: .. The human MGMT open reading frame (ORF) plasmid was purchased from OriGene (Cat# MGMT (RC229131, Taipei, Taiwan) and the cells transfected according to vendor’s instructions; MGMT-overexpressing U87MG cells were then allowed to grow at 37 °C in 5% CO 2 humidified atmosphere in Dulbecco’s modified Eagle’s medium (DMEM). ..

    Article Title: Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.
    Article Snippet: .. Low MGMT expressing cells U251, U87 and GB30 were transfected with human MGMT (NM 002412) Myc-DDK-tagged ORF clone plasmid (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA). ..

    Expressing:

    Article Title: Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.
    Article Snippet: .. Low MGMT expressing cells U251, U87 and GB30 were transfected with human MGMT (NM_002412) MycDDK-tagged ORF clone plasmid (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA). .. Cells were seeded in 6-well plates at 1 × 106 cells/well and transfected with 2.5 µg human MGMT- pCMV6 or empty vector.

    Article Title: Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.
    Article Snippet: .. Low MGMT expressing cells U251, U87 and GB30 were transfected with human MGMT (NM 002412) Myc-DDK-tagged ORF clone plasmid (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA). ..

    Transfection:

    Article Title: Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.
    Article Snippet: .. Low MGMT expressing cells U251, U87 and GB30 were transfected with human MGMT (NM_002412) MycDDK-tagged ORF clone plasmid (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA). .. Cells were seeded in 6-well plates at 1 × 106 cells/well and transfected with 2.5 µg human MGMT- pCMV6 or empty vector.

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment
    Article Snippet: MGMT (Invitrogen, 35-7000, 1:500) and β-actin (Sigma, A2228, 1:10,000) primary antibodies were incubated at 25°C for 90 min, and HRP-conjugated anti-mouse secondary antibodies (Cell Signaling; 1:2000) were incubated for 60 min at 25°C. .. Cells were seeded in 6-well plates at 1 × 10^6 cells/well and transfected with 2.5 μg human MGMT-pCMV6 ( NM_002412 ) (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA) for 72 h. Overexpression was confirmed by western blot. .. Cells at approximately 60% confluence in 6-well plates were transfected with 25 nM ON-TARGETplus SMARTpool siRNA targeting human MGMT (Dharmacon, L-008856-01-0005) or ON-TARGETplus control non-targeting pool siRNA (Dharmacon, D-001810-10-05) in OptiMEM with DharmaFECT 1 for 48 h. MGMT knockdown was confirmed by western blot.

    Article Title: Si-Jun-Zi-Tang potentiates temozolomide's anti-melanoma efficacy and reduces its hepatotoxicity.
    Article Snippet: Chemiluminescent detection was performed by applying Clarity Western ECL Substrate (Bio-Rad), and signal was quantified. .. A375 cells were transiently transfected with either MGMT Human Tagged ORF Clone (Origene, #NM_002412) or pcDNA4-Chk1-flag (Addgene, #22894, gift from Aziz Sancar) to overexpress MGMT and Chk1, respectively. .. Transfections were performed using Lipofectamine 3000 reagent (Invitrogen) in Opti-MEM medium (Gibco), following the manufacturer’s instructions and as previously described (Cao et al., 2014).

    Article Title: Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness
    Article Snippet: .. The human MGMT open reading frame (ORF) plasmid was purchased from OriGene (Cat# MGMT (RC229131, Taipei, Taiwan) and the cells transfected according to vendor’s instructions; MGMT-overexpressing U87MG cells were then allowed to grow at 37 °C in 5% CO 2 humidified atmosphere in Dulbecco’s modified Eagle’s medium (DMEM). ..

    Article Title: Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.
    Article Snippet: .. Low MGMT expressing cells U251, U87 and GB30 were transfected with human MGMT (NM 002412) Myc-DDK-tagged ORF clone plasmid (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA). ..

    Over Expression:

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment
    Article Snippet: MGMT (Invitrogen, 35-7000, 1:500) and β-actin (Sigma, A2228, 1:10,000) primary antibodies were incubated at 25°C for 90 min, and HRP-conjugated anti-mouse secondary antibodies (Cell Signaling; 1:2000) were incubated for 60 min at 25°C. .. Cells were seeded in 6-well plates at 1 × 10^6 cells/well and transfected with 2.5 μg human MGMT-pCMV6 ( NM_002412 ) (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA) for 72 h. Overexpression was confirmed by western blot. .. Cells at approximately 60% confluence in 6-well plates were transfected with 25 nM ON-TARGETplus SMARTpool siRNA targeting human MGMT (Dharmacon, L-008856-01-0005) or ON-TARGETplus control non-targeting pool siRNA (Dharmacon, D-001810-10-05) in OptiMEM with DharmaFECT 1 for 48 h. MGMT knockdown was confirmed by western blot.

    Western Blot:

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment
    Article Snippet: MGMT (Invitrogen, 35-7000, 1:500) and β-actin (Sigma, A2228, 1:10,000) primary antibodies were incubated at 25°C for 90 min, and HRP-conjugated anti-mouse secondary antibodies (Cell Signaling; 1:2000) were incubated for 60 min at 25°C. .. Cells were seeded in 6-well plates at 1 × 10^6 cells/well and transfected with 2.5 μg human MGMT-pCMV6 ( NM_002412 ) (Origene RC229131) or empty pCMV6-Entry Myc-DDK-tagged vector (Origene PS100001) using OptiMEM and Lipofectamine 3000 (Invitrogen, Waltham, MA) for 72 h. Overexpression was confirmed by western blot. .. Cells at approximately 60% confluence in 6-well plates were transfected with 25 nM ON-TARGETplus SMARTpool siRNA targeting human MGMT (Dharmacon, L-008856-01-0005) or ON-TARGETplus control non-targeting pool siRNA (Dharmacon, D-001810-10-05) in OptiMEM with DharmaFECT 1 for 48 h. MGMT knockdown was confirmed by western blot.

    Modification:

    Article Title: Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness
    Article Snippet: .. The human MGMT open reading frame (ORF) plasmid was purchased from OriGene (Cat# MGMT (RC229131, Taipei, Taiwan) and the cells transfected according to vendor’s instructions; MGMT-overexpressing U87MG cells were then allowed to grow at 37 °C in 5% CO 2 humidified atmosphere in Dulbecco’s modified Eagle’s medium (DMEM). ..



    Similar Products

    91
    Sino Biological human complementary dna
    Influence of TLS polymerases on the TMZ-induced mutation spectra in the presence and absence <t>of</t> <t>hMGMT.</t> A, illustration of the experimental system. dsDNA substrates were incubated with 400 μM TMZ three times. When indicated, damaged templates were treated with hMGMT. The <t>DNA</t> was heated and reannealed with NGS primer and 10x excess competitor to sequester the top strand. Then the primer extension was started by adding yPol δ. After 30 min of incubation with yPol δ, the second polymerase (either yPol ζ, hPol κ, or hPol η) was added, and the reaction was continued for another 30 min. B – D, mutation spectra produced on the TMZ-damaged DNA in the presence of the indicated second polymerase without hMGMT treatment. E–G, influences of the second polymerase on the C>T mutations were expressed as a ratio of the mutation frequencies at individual sites. CpC>T and CpT>T mutations (SBS11), other mutations (Others), and all mutations (All) are plotted as separate groups. H – J, the same experiments as in B – D were carried out using the templates that were treated with hMGMT. K, influences of hMGMT on the C>T and C>A mutations that were produced in the presence of indicated second polymerases. For hPol η reactions, only C>T mutations were analyzed because this polymerase did not produce considerable C>A mutations. Mutation frequencies mapped on the templates are shown in . hMGMT, human methylguanine methyltransferase; hPol κ, human Pol κ; hPol η, human Pol η; NGS, next-generation sequencing; SBS11, substitution signature 11; TLS, translesion synthesis; TMZ, temozolomide; yPol δ, yeast Pol δ.
    Human Complementary Dna, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/Human+MGMT+Gene+ORF+cDNA+clone+expression+plasmid/pmc12556801-188-0-9
    Average 91 stars, based on 1 article reviews
    human complementary dna - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    93
    OriGene mgmt human tagged orf
    Influence of TLS polymerases on the TMZ-induced mutation spectra in the presence and absence <t>of</t> <t>hMGMT.</t> A, illustration of the experimental system. dsDNA substrates were incubated with 400 μM TMZ three times. When indicated, damaged templates were treated with hMGMT. The <t>DNA</t> was heated and reannealed with NGS primer and 10x excess competitor to sequester the top strand. Then the primer extension was started by adding yPol δ. After 30 min of incubation with yPol δ, the second polymerase (either yPol ζ, hPol κ, or hPol η) was added, and the reaction was continued for another 30 min. B – D, mutation spectra produced on the TMZ-damaged DNA in the presence of the indicated second polymerase without hMGMT treatment. E–G, influences of the second polymerase on the C>T mutations were expressed as a ratio of the mutation frequencies at individual sites. CpC>T and CpT>T mutations (SBS11), other mutations (Others), and all mutations (All) are plotted as separate groups. H – J, the same experiments as in B – D were carried out using the templates that were treated with hMGMT. K, influences of hMGMT on the C>T and C>A mutations that were produced in the presence of indicated second polymerases. For hPol η reactions, only C>T mutations were analyzed because this polymerase did not produce considerable C>A mutations. Mutation frequencies mapped on the templates are shown in . hMGMT, human methylguanine methyltransferase; hPol κ, human Pol κ; hPol η, human Pol η; NGS, next-generation sequencing; SBS11, substitution signature 11; TLS, translesion synthesis; TMZ, temozolomide; yPol δ, yeast Pol δ.
    Mgmt Human Tagged Orf, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/MGMT+(NM_002412)+Human+Tagged+ORF+Clone/pm41771206-160-7-12
    Average 93 stars, based on 1 article reviews
    mgmt human tagged orf - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    R&D Systems mgmt antibody af3794
    Influence of TLS polymerases on the TMZ-induced mutation spectra in the presence and absence <t>of</t> <t>hMGMT.</t> A, illustration of the experimental system. dsDNA substrates were incubated with 400 μM TMZ three times. When indicated, damaged templates were treated with hMGMT. The <t>DNA</t> was heated and reannealed with NGS primer and 10x excess competitor to sequester the top strand. Then the primer extension was started by adding yPol δ. After 30 min of incubation with yPol δ, the second polymerase (either yPol ζ, hPol κ, or hPol η) was added, and the reaction was continued for another 30 min. B – D, mutation spectra produced on the TMZ-damaged DNA in the presence of the indicated second polymerase without hMGMT treatment. E–G, influences of the second polymerase on the C>T mutations were expressed as a ratio of the mutation frequencies at individual sites. CpC>T and CpT>T mutations (SBS11), other mutations (Others), and all mutations (All) are plotted as separate groups. H – J, the same experiments as in B – D were carried out using the templates that were treated with hMGMT. K, influences of hMGMT on the C>T and C>A mutations that were produced in the presence of indicated second polymerases. For hPol η reactions, only C>T mutations were analyzed because this polymerase did not produce considerable C>A mutations. Mutation frequencies mapped on the templates are shown in . hMGMT, human methylguanine methyltransferase; hPol κ, human Pol κ; hPol η, human Pol η; NGS, next-generation sequencing; SBS11, substitution signature 11; TLS, translesion synthesis; TMZ, temozolomide; yPol δ, yeast Pol δ.
    Mgmt Antibody Af3794, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/Human+MGMT+Antibody/pm40398419-86-0-6
    Average 93 stars, based on 1 article reviews
    mgmt antibody af3794 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Sino Biological gfpspark
    Influence of TLS polymerases on the TMZ-induced mutation spectra in the presence and absence <t>of</t> <t>hMGMT.</t> A, illustration of the experimental system. dsDNA substrates were incubated with 400 μM TMZ three times. When indicated, damaged templates were treated with hMGMT. The <t>DNA</t> was heated and reannealed with NGS primer and 10x excess competitor to sequester the top strand. Then the primer extension was started by adding yPol δ. After 30 min of incubation with yPol δ, the second polymerase (either yPol ζ, hPol κ, or hPol η) was added, and the reaction was continued for another 30 min. B – D, mutation spectra produced on the TMZ-damaged DNA in the presence of the indicated second polymerase without hMGMT treatment. E–G, influences of the second polymerase on the C>T mutations were expressed as a ratio of the mutation frequencies at individual sites. CpC>T and CpT>T mutations (SBS11), other mutations (Others), and all mutations (All) are plotted as separate groups. H – J, the same experiments as in B – D were carried out using the templates that were treated with hMGMT. K, influences of hMGMT on the C>T and C>A mutations that were produced in the presence of indicated second polymerases. For hPol η reactions, only C>T mutations were analyzed because this polymerase did not produce considerable C>A mutations. Mutation frequencies mapped on the templates are shown in . hMGMT, human methylguanine methyltransferase; hPol κ, human Pol κ; hPol η, human Pol η; NGS, next-generation sequencing; SBS11, substitution signature 11; TLS, translesion synthesis; TMZ, temozolomide; yPol δ, yeast Pol δ.
    Gfpspark, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/Human+MGMT+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-GFPSpark+tag/pm40341226-227-13-17
    Average 94 stars, based on 1 article reviews
    gfpspark - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    OriGene origene mgmt knockout kit
    Characterization of U1210 O 6 -methylguanine DNA methyltransferase <t>(MGMT)</t> <t>knockout</t> (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .
    Origene Mgmt Knockout Kit, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/MGMT+Human+Gene+Knockout+Kit/pmc12056744-42-17-17
    Average 93 stars, based on 1 article reviews
    origene mgmt knockout kit - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    OriGene human mgmt pcmv6
    Characterization of U1210 O 6 -methylguanine DNA methyltransferase <t>(MGMT)</t> <t>knockout</t> (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .
    Human Mgmt Pcmv6, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/MGMT+(NM_002412)+Human+Tagged+ORF+Clone/pmc12056744-52-16-21
    Average 93 stars, based on 1 article reviews
    human mgmt pcmv6 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    OriGene mgmt gene
    Characterization of U1210 O 6 -methylguanine DNA methyltransferase <t>(MGMT)</t> <t>knockout</t> (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .
    Mgmt Gene, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/MGMT+Human+Gene+Knockout+Kit/pmc12056744-42-11-17
    Average 93 stars, based on 1 article reviews
    mgmt gene - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    OriGene mgmt human tagged orf clone
    Characterization of U1210 O 6 -methylguanine DNA methyltransferase <t>(MGMT)</t> <t>knockout</t> (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .
    Mgmt Human Tagged Orf Clone, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mgmt/human+tagged+orf+clone/pm39969500-155-0-12
    Average 90 stars, based on 1 article reviews
    mgmt human tagged orf clone - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Influence of TLS polymerases on the TMZ-induced mutation spectra in the presence and absence of hMGMT. A, illustration of the experimental system. dsDNA substrates were incubated with 400 μM TMZ three times. When indicated, damaged templates were treated with hMGMT. The DNA was heated and reannealed with NGS primer and 10x excess competitor to sequester the top strand. Then the primer extension was started by adding yPol δ. After 30 min of incubation with yPol δ, the second polymerase (either yPol ζ, hPol κ, or hPol η) was added, and the reaction was continued for another 30 min. B – D, mutation spectra produced on the TMZ-damaged DNA in the presence of the indicated second polymerase without hMGMT treatment. E–G, influences of the second polymerase on the C>T mutations were expressed as a ratio of the mutation frequencies at individual sites. CpC>T and CpT>T mutations (SBS11), other mutations (Others), and all mutations (All) are plotted as separate groups. H – J, the same experiments as in B – D were carried out using the templates that were treated with hMGMT. K, influences of hMGMT on the C>T and C>A mutations that were produced in the presence of indicated second polymerases. For hPol η reactions, only C>T mutations were analyzed because this polymerase did not produce considerable C>A mutations. Mutation frequencies mapped on the templates are shown in . hMGMT, human methylguanine methyltransferase; hPol κ, human Pol κ; hPol η, human Pol η; NGS, next-generation sequencing; SBS11, substitution signature 11; TLS, translesion synthesis; TMZ, temozolomide; yPol δ, yeast Pol δ.

    Journal: The Journal of Biological Chemistry

    Article Title: Biochemical reconstitution of temozolomide-induced mutational processes

    doi: 10.1016/j.jbc.2025.110676

    Figure Lengend Snippet: Influence of TLS polymerases on the TMZ-induced mutation spectra in the presence and absence of hMGMT. A, illustration of the experimental system. dsDNA substrates were incubated with 400 μM TMZ three times. When indicated, damaged templates were treated with hMGMT. The DNA was heated and reannealed with NGS primer and 10x excess competitor to sequester the top strand. Then the primer extension was started by adding yPol δ. After 30 min of incubation with yPol δ, the second polymerase (either yPol ζ, hPol κ, or hPol η) was added, and the reaction was continued for another 30 min. B – D, mutation spectra produced on the TMZ-damaged DNA in the presence of the indicated second polymerase without hMGMT treatment. E–G, influences of the second polymerase on the C>T mutations were expressed as a ratio of the mutation frequencies at individual sites. CpC>T and CpT>T mutations (SBS11), other mutations (Others), and all mutations (All) are plotted as separate groups. H – J, the same experiments as in B – D were carried out using the templates that were treated with hMGMT. K, influences of hMGMT on the C>T and C>A mutations that were produced in the presence of indicated second polymerases. For hPol η reactions, only C>T mutations were analyzed because this polymerase did not produce considerable C>A mutations. Mutation frequencies mapped on the templates are shown in . hMGMT, human methylguanine methyltransferase; hPol κ, human Pol κ; hPol η, human Pol η; NGS, next-generation sequencing; SBS11, substitution signature 11; TLS, translesion synthesis; TMZ, temozolomide; yPol δ, yeast Pol δ.

    Article Snippet: Human complementary DNA of MGMT (hMGMT) was obtained from SinoBiological , amplified by PCR, and cloned into pET21a to express MGMT with a C-terminal His6-tag.

    Techniques: Mutagenesis, Incubation, Produced, Next-Generation Sequencing, Translesion Synthesis

    Characterization of U1210 O 6 -methylguanine DNA methyltransferase (MGMT) knockout (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Characterization of U1210 O 6 -methylguanine DNA methyltransferase (MGMT) knockout (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Knock-Out, Western Blot, In Vitro

    The effect of O 6 -methylguanine DNA methyltransferase (MGMT) expression on 3D growth of U1242 cells. (A) Representative photomicrographs of U1242 MGMT wildtype (WT) and knockout (KO) cell growth in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (B) Representative photomicrographs of U1242 MGMT WT cells, transfected with mock or MGMT siRNA, in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (C) Quantification of colony sizes of MGMT WT and KO cells. (D) Quantification of mock or MGMT siRNA colony sizes transfected U1242 MGMT WT cells. (E) Confirmation of MGMT knockdown on days 1 and 4 in U1242 cells.

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: The effect of O 6 -methylguanine DNA methyltransferase (MGMT) expression on 3D growth of U1242 cells. (A) Representative photomicrographs of U1242 MGMT wildtype (WT) and knockout (KO) cell growth in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (B) Representative photomicrographs of U1242 MGMT WT cells, transfected with mock or MGMT siRNA, in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (C) Quantification of colony sizes of MGMT WT and KO cells. (D) Quantification of mock or MGMT siRNA colony sizes transfected U1242 MGMT WT cells. (E) Confirmation of MGMT knockdown on days 1 and 4 in U1242 cells.

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Expressing, Knock-Out, Transfection, Knockdown

    Comparison of in vivo growth of U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells. (A) Cell lines and implanted cell numbers for each experimental group. (B) Representative H&E staining of mouse brains; (i): MGMT WT 20X, (ii): MGMT WT 50X, (iii): MGMT KO 20X, (iv): MGMT KO 50X ( n = 3 for each group, scale bars represent 200 μm).

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Comparison of in vivo growth of U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells. (A) Cell lines and implanted cell numbers for each experimental group. (B) Representative H&E staining of mouse brains; (i): MGMT WT 20X, (ii): MGMT WT 50X, (iii): MGMT KO 20X, (iv): MGMT KO 50X ( n = 3 for each group, scale bars represent 200 μm).

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Comparison, In Vivo, Knock-Out, Staining

    Effect of alisertib and/or carboplatin treatment on (A) O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells, and (B) Empty or MGMT overexpression vector transfected MGMT KO cell line (Each data point represents the mean value of three replicates from an independent experiment, n = 3, two-way ANOVA). (C) Kaplan-Meier survival curve of orthotopic xenograft U1242 MGMT WT cells implanted mice (vehicle, n = 5; alisertib only, n = 7; carboplatin only, n = 6; and alisertib + carboplatin, n = 7).

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Effect of alisertib and/or carboplatin treatment on (A) O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells, and (B) Empty or MGMT overexpression vector transfected MGMT KO cell line (Each data point represents the mean value of three replicates from an independent experiment, n = 3, two-way ANOVA). (C) Kaplan-Meier survival curve of orthotopic xenograft U1242 MGMT WT cells implanted mice (vehicle, n = 5; alisertib only, n = 7; carboplatin only, n = 6; and alisertib + carboplatin, n = 7).

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Knock-Out, Over Expression, Plasmid Preparation, Transfection

    Changes in DNA damage markers in U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells with alisertib and carboplatin treatment. (A) Representative western blots of DNA damage response markers in MGMT WT and MGMT KO cells treated with 0 to 10 μM alisertib, carboplatin, or alisertib + carboplatin. Quantification of (B) pATM, (C) pBRCA1, (D) pChk1, (E) . pChk2, and (F) pHistone-H2AX protein levels. Each data point represents the values from independent experiments. n = 3, two-way ANOVA.

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Changes in DNA damage markers in U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells with alisertib and carboplatin treatment. (A) Representative western blots of DNA damage response markers in MGMT WT and MGMT KO cells treated with 0 to 10 μM alisertib, carboplatin, or alisertib + carboplatin. Quantification of (B) pATM, (C) pBRCA1, (D) pChk1, (E) . pChk2, and (F) pHistone-H2AX protein levels. Each data point represents the values from independent experiments. n = 3, two-way ANOVA.

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Knock-Out, Western Blot

    Characterization of U1210 O 6 -methylguanine DNA methyltransferase (MGMT) knockout (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Characterization of U1210 O 6 -methylguanine DNA methyltransferase (MGMT) knockout (KO) cells. (A) Confirmation of MGMT KO in U1242 glioblastoma (GBM) cells by western blotting. (B) MGMT KO confers temozolomide (TMZ) sensitivity to U1242 cells. Wildtype U1242 cells are resistant to TMZ induced apoptosis as indicated by minimal detection of cleaved PARP (C PARP). MGMT KO U1242 cells undergo substantially more apoptosis after TMZ treatment. Cells were treated with 20 μM TMZ for 72 h and subjected to western blotting. (C) Wildtype and MGMT KO U1242 cells exhibit nearly identical proliferation rates. Growth curves of MGMT WT and MGMT KO cells were performed in vitro .

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Knock-Out, Western Blot, In Vitro

    The effect of O 6 -methylguanine DNA methyltransferase (MGMT) expression on 3D growth of U1242 cells. (A) Representative photomicrographs of U1242 MGMT wildtype (WT) and knockout (KO) cell growth in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (B) Representative photomicrographs of U1242 MGMT WT cells, transfected with mock or MGMT siRNA, in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (C) Quantification of colony sizes of MGMT WT and KO cells. (D) Quantification of mock or MGMT siRNA colony sizes transfected U1242 MGMT WT cells. (E) Confirmation of MGMT knockdown on days 1 and 4 in U1242 cells.

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: The effect of O 6 -methylguanine DNA methyltransferase (MGMT) expression on 3D growth of U1242 cells. (A) Representative photomicrographs of U1242 MGMT wildtype (WT) and knockout (KO) cell growth in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (B) Representative photomicrographs of U1242 MGMT WT cells, transfected with mock or MGMT siRNA, in soft agar on days 1, 4, 7, and 10 (scale bars represent 50 μm). (C) Quantification of colony sizes of MGMT WT and KO cells. (D) Quantification of mock or MGMT siRNA colony sizes transfected U1242 MGMT WT cells. (E) Confirmation of MGMT knockdown on days 1 and 4 in U1242 cells.

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Expressing, Knock-Out, Transfection, Knockdown

    Comparison of in vivo growth of U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells. (A) Cell lines and implanted cell numbers for each experimental group. (B) Representative H&E staining of mouse brains; (i): MGMT WT 20X, (ii): MGMT WT 50X, (iii): MGMT KO 20X, (iv): MGMT KO 50X ( n = 3 for each group, scale bars represent 200 μm).

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Comparison of in vivo growth of U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells. (A) Cell lines and implanted cell numbers for each experimental group. (B) Representative H&E staining of mouse brains; (i): MGMT WT 20X, (ii): MGMT WT 50X, (iii): MGMT KO 20X, (iv): MGMT KO 50X ( n = 3 for each group, scale bars represent 200 μm).

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Comparison, In Vivo, Knock-Out, Staining

    Effect of alisertib and/or carboplatin treatment on (A) O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells, and (B) Empty or MGMT overexpression vector transfected MGMT KO cell line (Each data point represents the mean value of three replicates from an independent experiment, n = 3, two-way ANOVA). (C) Kaplan-Meier survival curve of orthotopic xenograft U1242 MGMT WT cells implanted mice (vehicle, n = 5; alisertib only, n = 7; carboplatin only, n = 6; and alisertib + carboplatin, n = 7).

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Effect of alisertib and/or carboplatin treatment on (A) O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells, and (B) Empty or MGMT overexpression vector transfected MGMT KO cell line (Each data point represents the mean value of three replicates from an independent experiment, n = 3, two-way ANOVA). (C) Kaplan-Meier survival curve of orthotopic xenograft U1242 MGMT WT cells implanted mice (vehicle, n = 5; alisertib only, n = 7; carboplatin only, n = 6; and alisertib + carboplatin, n = 7).

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Knock-Out, Over Expression, Plasmid Preparation, Transfection

    Changes in DNA damage markers in U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells with alisertib and carboplatin treatment. (A) Representative western blots of DNA damage response markers in MGMT WT and MGMT KO cells treated with 0 to 10 μM alisertib, carboplatin, or alisertib + carboplatin. Quantification of (B) pATM, (C) pBRCA1, (D) pChk1, (E) . pChk2, and (F) pHistone-H2AX protein levels. Each data point represents the values from independent experiments. n = 3, two-way ANOVA.

    Journal: Frontiers in Cellular Neuroscience

    Article Title: O 6 -methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo , and sensitivity to alisertib-carboplatin combination treatment

    doi: 10.3389/fncel.2025.1552015

    Figure Lengend Snippet: Changes in DNA damage markers in U1242 O 6 -methylguanine DNA methyltransferase (MGMT) wildtype (WT) and knockout (KO) cells with alisertib and carboplatin treatment. (A) Representative western blots of DNA damage response markers in MGMT WT and MGMT KO cells treated with 0 to 10 μM alisertib, carboplatin, or alisertib + carboplatin. Quantification of (B) pATM, (C) pBRCA1, (D) pChk1, (E) . pChk2, and (F) pHistone-H2AX protein levels. Each data point represents the values from independent experiments. n = 3, two-way ANOVA.

    Article Snippet: Two separate guide RNAs (gRNAs) that target exon 2 of the MGMT gene are provided by the Origene MGMT Knockout Kit ( KN201612 ).

    Techniques: Knock-Out, Western Blot